SIMILAR PATTERNS OF AMINO ACIDS FOR 3JWQ_D_VIAD901_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1dxe | 2-DEHYDRO-3-DEOXY-GALACTARATE ALDOLASE (Escherichiacoli) |
PF03328(HpcH_HpaI) | 5 | ARG A 128ALA A 51LEU A 65GLN A 61PHE A 58 | None | 1.39A | 3jwqA-1dxeA:undetectable3jwqD-1dxeA:undetectable | 3jwqA-1dxeA:20.363jwqD-1dxeA:20.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1hjv | CHITINASE-3 LIKEPROTEIN 1 (Homo sapiens) |
PF00704(Glyco_hydro_18) | 5 | ARG A 117LEU A 153ALA A 59PHE A 161PHE A 119 | SO4 A1386 (-4.2A)NoneNoneNoneNone | 1.18A | 3jwqA-1hjvA:undetectable3jwqD-1hjvA:undetectable | 3jwqA-1hjvA:22.053jwqD-1hjvA:22.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jr7 | HYPOTHETICAL 37.4KDA PROTEIN INILEY-GABD INTERGENICREGION (Escherichiacoli) |
PF08943(CsiD) | 5 | ARG A 294TYR A 165ALA A 129MET A 157LEU A 150 | None | 1.43A | 3jwqA-1jr7A:undetectable3jwqD-1jr7A:undetectable | 3jwqA-1jr7A:21.633jwqD-1jr7A:21.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1lq2 | BETA-D-GLUCANGLUCOHYDROLASEISOENZYME EXO1 (Hordeum vulgare) |
PF00933(Glyco_hydro_3)PF01915(Glyco_hydro_3_C) | 5 | ARG A 126LEU A 133ALA A 143PHE A 109LEU A 115 | None | 1.18A | 3jwqA-1lq2A:undetectable3jwqD-1lq2A:undetectable | 3jwqA-1lq2A:18.913jwqD-1lq2A:18.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ml4 | ASPARTATETRANSCARBAMOYLASE (Pyrococcusabyssi) |
PF00185(OTCace)PF02729(OTCace_N) | 5 | HIS A 135LEU A 140ALA A 114PHE A 62LEU A 47 | PAL A 385 (-3.9A)NoneNoneNoneNone | 1.46A | 3jwqA-1ml4A:undetectable3jwqD-1ml4A:undetectable | 3jwqA-1ml4A:22.103jwqD-1ml4A:22.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homo sapiens) |
PF00233(PDEase_I) | 5 | GLN A 962TYR A 736HIS A 737LEU A 984GLN A 988 | NoneIBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneIBM A2111 (-3.3A) | 1.47A | 3jwqA-1sojA:37.43jwqD-1sojA:37.1 | 3jwqA-1sojA:24.243jwqD-1sojA:24.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homo sapiens) |
PF00233(PDEase_I) | 6 | TYR A 736HIS A 737LEU A 895LEU A 984GLN A 988PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneNoneIBM A2111 (-3.3A)IBM A2111 (-3.6A) | 1.07A | 3jwqA-1sojA:37.43jwqD-1sojA:37.1 | 3jwqA-1sojA:24.243jwqD-1sojA:24.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homo sapiens) |
PF00233(PDEase_I) | 6 | TYR A 736HIS A 737LEU A 895PHE A 959GLN A 988PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneNoneIBM A2111 (-3.3A)IBM A2111 (-3.6A) | 0.45A | 3jwqA-1sojA:37.43jwqD-1sojA:37.1 | 3jwqA-1sojA:24.243jwqD-1sojA:24.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1z8l | GLUTAMATECARBOXYPEPTIDASE II (Homo sapiens) |
PF02225(PA)PF04253(TFR_dimer)PF04389(Peptidase_M28) | 5 | TYR A 692HIS A 689LEU A 671LEU A 632PHE A 639 | None | 1.31A | 3jwqA-1z8lA:3.03jwqD-1z8lA:3.0 | 3jwqA-1z8lA:18.083jwqD-1z8lA:18.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zkl | HIGH-AFFINITYCAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 7A (Homo sapiens) |
PF00233(PDEase_I) | 5 | TYR A 211HIS A 212PHE A 384GLN A 413PHE A 416 | IBM A 503 (-4.6A)NoneIBM A 503 (-4.5A)IBM A 503 (-3.0A)IBM A 503 (-3.4A) | 0.61A | 3jwqA-1zklA:38.13jwqD-1zklA:37.7 | 3jwqA-1zklA:27.693jwqD-1zklA:27.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jgq | TRIOSEPHOSPHATEISOMERASE (Helicobacterpylori) |
PF00121(TIM) | 5 | TYR A 194HIS A 179LEU A 140ALA A 163LEU A 87 | None | 1.19A | 3jwqA-2jgqA:undetectable3jwqD-2jgqA:undetectable | 3jwqA-2jgqA:24.463jwqD-2jgqA:24.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qyk | CYCLIC AMP-SPECIFICPHOSPHODIESTERASEHSPDE4A10 (Homo sapiens) |
PF00233(PDEase_I) | 6 | TYR A 371HIS A 372PHE A 552MET A 569GLN A 581PHE A 584 | NPV A 3 (-4.4A)NPV A 3 (-4.6A)NPV A 3 (-4.8A)NPV A 3 (-3.1A)NPV A 3 (-3.1A)NPV A 3 (-3.3A) | 0.84A | 3jwqA-2qykA:39.23jwqD-2qykA:38.8 | 3jwqA-2qykA:29.073jwqD-2qykA:29.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r8q | CLASS IPHOSPHODIESTERASEPDEB1 (Leishmaniamajor) |
PF00233(PDEase_I) | 5 | TYR A 680HIS A 681LEU A 883GLN A 887PHE A 890 | IBM A 3 ( 4.7A)IBM A 3 ( 4.8A)NoneIBM A 3 (-3.3A)IBM A 3 (-3.6A) | 1.14A | 3jwqA-2r8qA:40.53jwqD-2r8qA:40.0 | 3jwqA-2r8qA:31.583jwqD-2r8qA:31.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r8q | CLASS IPHOSPHODIESTERASEPDEB1 (Leishmaniamajor) |
PF00233(PDEase_I) | 6 | TYR A 680HIS A 681PHE A 857MET A 874GLN A 887PHE A 890 | IBM A 3 ( 4.7A)IBM A 3 ( 4.8A)IBM A 3 (-4.9A)IBM A 3 ( 3.8A)IBM A 3 (-3.3A)IBM A 3 (-3.6A) | 0.77A | 3jwqA-2r8qA:40.53jwqD-2r8qA:40.0 | 3jwqA-2r8qA:31.583jwqD-2r8qA:31.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3a2q | 6-AMINOHEXANOATE-CYCLIC-DIMER HYDROLASE (Arthrobactersp. KI72) |
PF01425(Amidase) | 5 | ARG A 108ALA A 216PHE A 103LEU A 71PHE A 112 | None | 1.31A | 3jwqA-3a2qA:undetectable3jwqD-3a2qA:undetectable | 3jwqA-3a2qA:21.083jwqD-3a2qA:21.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3b2r | CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 7 | TYR A 612HIS A 613LEU A 725ALA A 767PHE A 786GLN A 817PHE A 820 | VDN A 1 (-4.8A)VDN A 1 (-4.3A)NoneVDN A 1 ( 3.8A)NoneVDN A 1 (-3.0A)VDN A 1 (-3.6A) | 0.52A | 3jwqA-3b2rA:45.03jwqD-3b2rA:44.6 | 3jwqA-3b2rA:93.333jwqD-3b2rA:93.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bj1 | HEMOGLOBIN ALPHAHEMOGLOBIN BETA (Percaflavescens) |
PF00042(Globin) | 5 | ARG A 31GLN B 131ALA B 26PHE B 130LEU B 118 | None | 1.37A | 3jwqA-3bj1A:undetectable3jwqD-3bj1A:undetectable | 3jwqA-3bj1A:19.583jwqD-3bj1A:19.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3bjc | CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 7 | TYR A 612HIS A 613LEU A 725ALA A 767PHE A 786GLN A 817PHE A 820 | None MG A 877 (-4.4A)NoneWAN A 901 ( 3.9A)WAN A 901 (-4.8A)WAN A 901 (-3.1A)WAN A 901 (-3.7A) | 0.44A | 3jwqA-3bjcA:47.83jwqD-3bjcA:47.3 | 3jwqA-3bjcA:35.693jwqD-3bjcA:35.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ccy | PUTATIVE TETR-FAMILYTRANSCRIPTIONALREGULATOR (Bordetellaparapertussis) |
PF00440(TetR_N) | 5 | ARG A 136GLN A 141LEU A 142ALA A 183LEU A 131 | None | 1.26A | 3jwqA-3ccyA:undetectable3jwqD-3ccyA:undetectable | 3jwqA-3ccyA:23.283jwqD-3ccyA:23.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3f6t | ASPARTATEAMINOTRANSFERASE (Lactobacillusacidophilus) |
PF00155(Aminotran_1_2) | 5 | LEU A 153ALA A 414LEU A 48GLN A 46PHE A 314 | None | 1.36A | 3jwqA-3f6tA:undetectable3jwqD-3f6tA:undetectable | 3jwqA-3f6tA:22.163jwqD-3f6tA:22.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 5 | TYR A 325HIS A 326PHE A 506GLN A 535PHE A 538 | NoneD71 A 901 (-4.5A)D71 A 901 (-4.8A)D71 A 901 (-3.1A)D71 A 901 (-3.9A) | 0.63A | 3jwqA-3g4gA:38.93jwqD-3g4gA:38.6 | 3jwqA-3g4gA:25.943jwqD-3g4gA:25.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ibj | CGMP-DEPENDENT3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I)PF01590(GAF)PF13185(GAF_2) | 5 | TYR A 655HIS A 656LEU A 770GLN A 859PHE A 862 | None | 0.69A | 3jwqA-3ibjA:38.53jwqD-3ibjA:38.4 | 3jwqA-3ibjA:21.083jwqD-3ibjA:21.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n6z | PUTATIVEIMMUNOGLOBULIN A1PROTEASE (Bacteroidesovatus) |
no annotation | 5 | ARG A 149LEU A 93ALA A 156PHE A 141LEU A 172 | None | 1.39A | 3jwqA-3n6zA:undetectable3jwqD-3n6zA:undetectable | 3jwqA-3n6zA:19.433jwqD-3n6zA:19.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o57 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 5 | TYR A 233HIS A 234PHE A 414GLN A 443PHE A 446 | NoneNoneZG2 A 506 (-4.4A)ZG2 A 506 (-3.3A)ZG2 A 506 (-3.6A) | 0.58A | 3jwqA-3o57A:39.13jwqD-3o57A:38.8 | 3jwqA-3o57A:28.303jwqD-3o57A:28.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o5n | SH3 AND MULTIPLEANKYRIN REPEATDOMAINS PROTEIN 3 (Mus musculus) |
PF00595(PDZ) | 5 | ARG A 725GLN A 726ALA A 696LEU A 660PHE A 656 | None | 1.09A | 3jwqA-3o5nA:undetectable3jwqD-3o5nA:undetectable | 3jwqA-3o5nA:11.893jwqD-3o5nA:11.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rza | TRIPEPTIDASE (Staphylococcusaureus) |
PF01546(Peptidase_M20)PF07687(M20_dimer) | 5 | GLN A 136LEU A 157ALA A 48LEU A 31GLN A 28 | NoneNone CA A 405 (-4.9A)NoneNone | 1.45A | 3jwqA-3rzaA:undetectable3jwqD-3rzaA:undetectable | 3jwqA-3rzaA:22.523jwqD-3rzaA:22.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 6 | TYR A 159HIS A 160PHE A 340MET A 357GLN A 369PHE A 372 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)PHE A 340 (-1.3A)MET A 357 (-0.0A)GLN A 369 (-0.6A)PHE A 372 (-1.3A) | 1.01A | 3jwqA-3sl5A:39.23jwqD-3sl5A:38.8 | 3jwqA-3sl5A:28.413jwqD-3sl5A:28.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ui7 | CAMP ANDCAMP-INHIBITED CGMP3',5'-CYCLICPHOSPHODIESTERASE10A (Homo sapiens) |
PF00233(PDEase_I) | 7 | TYR A 524HIS A 525LEU A 635PHE A 696MET A 713GLN A 726PHE A 729 | C1L A 1 ( 4.8A)C1L A 1 (-4.1A)NoneC1L A 1 ( 4.7A)C1L A 1 (-3.7A)C1L A 1 (-2.9A)C1L A 1 (-3.5A) | 0.69A | 3jwqA-3ui7A:44.33jwqD-3ui7A:43.8 | 3jwqA-3ui7A:42.113jwqD-3ui7A:42.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3v94 | CYCLIC NUCLEOTIDESPECIFICPHOSPHODIESTERASE (Trypanosomacruzi) |
PF00233(PDEase_I) | 6 | TYR A 367HIS A 368ALA A 524PHE A 542GLN A 570PHE A 573 | WYQ A 701 (-4.5A)NoneNoneWYQ A 701 (-4.7A)WYQ A 701 (-3.3A)WYQ A 701 (-3.4A) | 0.74A | 3jwqA-3v94A:37.03jwqD-3v94A:36.8 | 3jwqA-3v94A:27.673jwqD-3v94A:27.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ze7 | PERIPLASMIC [NIFESE]HYDROGENASE, LARGESUBUNIT,SELENOCYSTEINE-CONTAINING (Desulfovibriovulgaris) |
PF00374(NiFeSe_Hases) | 5 | GLN B 116ALA B 85MET B 183GLN B 189PHE B 110 | NoneNoneNoneNoneH2S B 503 (-4.8A) | 1.42A | 3jwqA-3ze7B:undetectable3jwqD-3ze7B:undetectable | 3jwqA-3ze7B:21.443jwqD-3ze7B:21.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dzt | AQUALYSIN-1 (Thermusaquaticus) |
PF00082(Peptidase_S8) | 5 | ARG A 16GLN A 15LEU A 18ALA A 186LEU A 197 | None CA A 302 (-3.5A)NoneNoneNone | 1.43A | 3jwqA-4dztA:undetectable3jwqD-4dztA:undetectable | 3jwqA-4dztA:19.523jwqD-4dztA:19.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ea1 | DEHYDROSQUALENESYNTHASE (Staphylococcusaureus) |
PF00494(SQS_PSY) | 5 | ARG A 34GLN A 33LEU A 145ALA A 245PHE A 26 | None | 1.35A | 3jwqA-4ea1A:2.73jwqD-4ea1A:3.0 | 3jwqA-4ea1A:19.763jwqD-4ea1A:19.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gjh | TNFRECEPTOR-ASSOCIATEDFACTOR 5 (Mus musculus) |
no annotation | 5 | ARG A 429GLN A 428LEU A 500PHE A 411LEU A 432 | None | 1.39A | 3jwqA-4gjhA:undetectable3jwqD-4gjhA:undetectable | 3jwqA-4gjhA:19.763jwqD-4gjhA:19.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4htz | CGMP-DEPENDENT3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 7 | TYR A 655HIS A 656LEU A 770PHE A 830MET A 847GLN A 859PHE A 862 | None | 0.66A | 3jwqA-4htzA:44.33jwqD-4htzA:43.9 | 3jwqA-4htzA:35.543jwqD-4htzA:35.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4htz | CGMP-DEPENDENT3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 5 | TYR A 655HIS A 656LEU A 770PHE A 830MET A 848 | None | 1.28A | 3jwqA-4htzA:44.33jwqD-4htzA:43.9 | 3jwqA-4htzA:35.543jwqD-4htzA:35.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4i15 | CLASS 1PHOSPHODIESTERASEPDEB1 (Trypanosomabrucei) |
PF00233(PDEase_I) | 5 | TYR A 668HIS A 669MET A 861GLN A 874PHE A 877 | None | 0.88A | 3jwqA-4i15A:39.43jwqD-4i15A:39.0 | 3jwqA-4i15A:32.963jwqD-4i15A:32.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4i15 | CLASS 1PHOSPHODIESTERASEPDEB1 (Trypanosomabrucei) |
PF00233(PDEase_I) | 5 | TYR A 668HIS A 669PHE A 844MET A 861PHE A 877 | None | 0.58A | 3jwqA-4i15A:39.43jwqD-4i15A:39.0 | 3jwqA-4i15A:32.963jwqD-4i15A:32.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4irx | SUGAR ABCTRANSPORTER,PERIPLASMICSUGAR-BINDINGPROTEIN (Caulobactervibrioides) |
PF13407(Peripla_BP_4) | 5 | GLN A 278HIS A 137LEU A 306MET A 55LEU A 59 | INS A 401 (-3.1A)NoneNoneNoneNone | 1.48A | 3jwqA-4irxA:undetectable3jwqD-4irxA:undetectable | 3jwqA-4irxA:24.313jwqD-4irxA:24.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4n9x | PUTATIVEMONOOXYGENASE (Pectobacteriumatrosepticum) |
PF01494(FAD_binding_3) | 5 | ARG A 28GLN A 23LEU A 22ALA A 163LEU A 130 | None | 1.49A | 3jwqA-4n9xA:undetectable3jwqD-4n9xA:undetectable | 3jwqA-4n9xA:21.503jwqD-4n9xA:21.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ntl | LIPOPROTEIN, YAECFAMILY (Enterococcusfaecalis) |
PF03180(Lipoprotein_9) | 5 | TYR A 228HIS A 88LEU A 184PHE A 112PHE A 200 | NoneEDO A 307 (-3.1A)NoneNoneNone | 1.30A | 3jwqA-4ntlA:undetectable3jwqD-4ntlA:undetectable | 3jwqA-4ntlA:22.413jwqD-4ntlA:22.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q1l | SNAKE VENOMMETALLOPROTEINASELEUCUROLYSIN-A (Bothropsleucurus) |
PF01421(Reprolysin) | 5 | GLN A 185HIS A 142ALA A 124PHE A 178MET A 47 | None ZN A 302 (-3.2A)NoneNoneNone | 1.47A | 3jwqA-4q1lA:undetectable3jwqD-4q1lA:undetectable | 3jwqA-4q1lA:21.393jwqD-4q1lA:21.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4tmc | OLD YELLOW ENZYME (Kluyveromycesmarxianus) |
PF00724(Oxidored_FMN) | 5 | GLN A 62TYR A 346ALA A 333LEU A 27PHE A 17 | None | 1.37A | 3jwqA-4tmcA:undetectable3jwqD-4tmcA:undetectable | 3jwqA-4tmcA:21.163jwqD-4tmcA:21.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wxm | TRANSCRIPTIONALREGULATOR FLEQ (Pseudomonasaeruginosa) |
PF06490(FleQ) | 5 | ARG A 125GLN A 122LEU A 118ALA A 21LEU A 46 | None | 1.44A | 3jwqA-4wxmA:undetectable3jwqD-4wxmA:undetectable | 3jwqA-4wxmA:17.883jwqD-4wxmA:17.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wzi | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 5 | TYR A 405HIS A 406PHE A 586GLN A 615PHE A 618 | None MG A 804 ( 4.9A)NoneNoneNone | 0.46A | 3jwqA-4wziA:39.03jwqD-4wziA:38.9 | 3jwqA-4wziA:22.263jwqD-4wziA:22.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5b25 | CALCIUM/CALMODULIN-DEPENDENT3',5'-CYCLICNUCLEOTIDEPHOSPHODIESTERASE 1B (Homo sapiens) |
PF00233(PDEase_I) | 5 | TYR A 222HIS A 223PHE A 392GLN A 421PHE A 424 | None4QJ A 603 ( 4.9A)GOL A 607 (-3.9A)4QJ A 603 (-3.0A)4QJ A 603 (-3.5A) | 0.66A | 3jwqA-5b25A:37.83jwqD-5b25A:37.5 | 3jwqA-5b25A:27.933jwqD-5b25A:27.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5h2r | PHOSPHODIESTERASE (Trypanosomabrucei) |
no annotation | 5 | TYR A 668HIS A 669LEU A 871GLN A 875PHE A 878 | LLN A1003 ( 4.8A)NoneLLN A1003 (-4.9A)LLN A1003 (-3.0A)LLN A1003 (-3.8A) | 1.08A | 3jwqA-5h2rA:40.43jwqD-5h2rA:39.9 | 3jwqA-5h2rA:34.863jwqD-5h2rA:34.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5h2r | PHOSPHODIESTERASE (Trypanosomabrucei) |
no annotation | 6 | TYR A 668HIS A 669PHE A 845MET A 862GLN A 875PHE A 878 | LLN A1003 ( 4.8A)NoneLLN A1003 (-4.6A)LLN A1003 (-3.5A)LLN A1003 (-3.0A)LLN A1003 (-3.8A) | 0.71A | 3jwqA-5h2rA:40.43jwqD-5h2rA:39.9 | 3jwqA-5h2rA:34.863jwqD-5h2rA:34.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ohj | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
no annotation | 6 | TYR A 405HIS A 406PHE A 586MET A 603GLN A 615PHE A 618 | NoneNone9VE A 801 (-3.6A)9VE A 801 (-3.6A)9VE A 801 (-3.2A)9VE A 801 (-3.9A) | 0.72A | 3jwqA-5ohjA:39.23jwqD-5ohjA:39.0 | 3jwqA-5ohjA:13.643jwqD-5ohjA:13.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wh6 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
no annotation | 6 | TYR A 159HIS A 160PHE A 340MET A 357GLN A 369PHE A 372 | AKJ A 601 ( 4.7A)NoneAKJ A 601 (-4.5A)AKJ A 601 (-3.4A)AKJ A 601 (-3.0A)AKJ A 601 (-4.1A) | 0.82A | 3jwqA-5wh6A:39.53jwqD-5wh6A:39.1 | 3jwqA-5wh6A:undetectable3jwqD-5wh6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ax8 | METHIONINE-TRNALIGASE (Mycobacteriumtuberculosis) |
no annotation | 5 | ARG A 33HIS A 290ALA A 11LEU A 84GLN A 81 | NoneME8 A 801 (-4.7A)ME8 A 801 (-3.1A)NoneNone | 1.49A | 3jwqA-6ax8A:undetectable3jwqD-6ax8A:undetectable | 3jwqA-6ax8A:12.383jwqD-6ax8A:12.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6bk5 | UBIQUITIN LIGASE CBL (Salpingoecarosetta) |
no annotation | 5 | GLN A 206LEU A 205ALA A 168LEU A 281PHE A 225 | None | 1.48A | 3jwqA-6bk5A:3.03jwqD-6bk5A:3.2 | 3jwqA-6bk5A:13.833jwqD-6bk5A:13.83 |